Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Repaglinide dose response? A clinician's viewpoint

D S Schade1

  • 1Department of Internal Medicine, Division of Endocrinology & Metabolism, University of New Mexico, Health Sciences Center, Albuquerque, New Mexico, USA. dschade@salud.unm.edu

Diabetes Technology & Therapeutics
|July 28, 2001
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lispro insulin: benefits and limitations.

Trends in endocrinology and metabolism: TEM·2008
Same author

Ten pivotal questions about diabetic ketoacidosis. Answers that clarify new concepts in treatment.

Postgraduate medicine·2001
Same author

Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms.

The Journal of clinical endocrinology and metabolism·2001
Same author

A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey.

Diabetes care·2001
Same author

Potato-lactulose breath hydrogen testing as a function of gastric motility in diabetes mellitus.

Diabetes technology & therapeutics·2001
Same author

Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review.

Diabetes, obesity & metabolism·2001
Same journal

Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Invited Commentary: Using Large Clinical Databases.

Diabetes technology & therapeutics·2026
Same journal

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Diabetes technology & therapeutics·2026
Same journal

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study.

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> "Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting".

Diabetes technology & therapeutics·2026
Same journal

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Diabetes technology & therapeutics·2026
See all related articles